SCHEMBL21718312

SCHEMBL21718312

c1ccc2c(c1)c1cccc3c4cc(-c5cccc6c5c5cccc7c8c(-c9ccc%10c(c9)c9cccc%11c%12ccccc%12n%10c%119)cccc8n6c57)ccc4n2c13

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
MEN1 O00255 4/20 0.37
MAPT P10636 4/20 0.37
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
HTT P42858 3/20 0.37
POLB P06746 1/20 0.37
TSPO P30536 3/20 0.34
DUSP3 P51452 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
FTO Q9C0B1 1/20 0.33
NPY5R Q15761 1/20 0.32
HSD17B10 Q99714 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TDP1 Q9NUW8 2/20 0.30
MAPK1 P28482 1/20 0.30
HBB P68871 1/20 0.30
RECQL P46063 1/20 0.30
PLEC Q15149 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23814096 1.00 KDM4E (0.37) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL25459782 0.94 TSPO (0.39) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL25459788 0.94 TSPO (0.39) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL22679628 0.92 NPY5R (0.33) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL23814088 0.91 KDM4E (0.37) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL23823568 0.91 TSPO (0.37) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL23814191 0.91 TSPO (0.37) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL23823661 0.90 KDM4E (0.39) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL23823558 0.90 TSPO (0.38) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL25459767 0.90 TSPO (0.38) KDM4EMEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 KDM4E 2210/4885MEN1 1680/4885MAPT 1866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.